The Patient’s Perspective: Medication Safety and Satisfaction in Care
Join us to focus on patients and their experiences with medication safety. Learn how to empower patients through education and trust-building while addressing medication risk in an ACO setting. Discover how patient-centered strategies can enhance satisfaction, improve quality of care, and prevent costly ER visits and hospitalizations. This is the third installment in our investigative webinar […]
The Pharmacist Perspective: Decoding the Data on Complex Multi-Drug Interactions
Join us to decode the data on complex patient cases. This session highlights the role of Precision Clinical Pharmacists in uncovering simultaneous multi-drug, drug-disease, and drug-gene interactions and delivering actionable, evidence-based recommendations to optimize the medication regimen. We invite you to submit a de-identified complex patient case for a chance to have it featured in our […]
The Hidden Culprit: Uncovering Medication Risk in Value-based Care
ACOs have made great progress in reducing total cost of care. Yet, one elusive culprit continues to drive avoidable costs and poorer outcomes: adverse drug events (ADEs). Many avoidable costly hospitalizations and ER visits can be traced back to suboptimal medication regimens. In fact, research reveals that patients with polypharmacy drive a substantial portion of […]
From Risk To Results: Managing Medication Safety in Value-Based Care
Details Patients on multiple medications face increased risks of adverse drug events (ADEs), leading to higher rates of ER visits and hospital admissions. These polypharmacy patients drive a substantial portion of medical loss ratios, presenting unique and complex challenges for care teams. In this session, we will explore how ACOs can implement a proactive strategy […]
From Risk To Results: Managing Medication Safety in Value-Based Care
Details Patients on multiple medications face increased risks of adverse drug events (ADEs), leading to higher rates of ER visits and hospital admissions. These polypharmacy patients drive a substantial portion of medical loss ratios, presenting unique and complex challenges for care teams. In this session, we will explore how ACOs can implement a proactive strategy […]
Deprescribing in High-Risk Patients: A Proven Path to ADE Prevention
Managing polypharmacy among high-risk patients is crucial to improving outcomes and controlling costs. Join us for an in-depth webinar on targeted deprescribing as a strategic approach to reducing polypharmacy and preventing adverse drug events (ADEs). This session is designed for ACO leaders and healthcare providers committed to optimizing care within the framework of value-based care. […]
Measuring and Managing Adverse Drug Event Concern in Value-Based Care
Perspectives on Medication Risk for ACOs Adverse Drug Events (ADEs) can lead to increased healthcare costs and, most importantly, harm to patients. They include falls, ER visits, hospitalizations and re-hospitalizations, morbidity, and even premature death. In this session, we will discuss how ACOs can develop a predictive, proactive medication safety strategy to materially reduce concern […]
Forecasting the Risk of Adverse Drug Events & Simultaneous Interactions
A Strategic Approach Using Real-world Data and Predict Analytics Panelists: Sebastian Härtter, PharmD, PhD, Lawrence J. Lesko, PhD, Veronique Michaud, PhD, Jacques Turgeon, PhD In this open-access educational session, explore how a strategic approach using real-world data and predictive analytics can make pharmacovigilance departments an even more integral part of the drug development process, reducing […]
The Future of Pharmacy and Medication Safety in Value-Based Care
In this webinar, we explore the evolving role of pharmacists within the healthcare landscape and their crucial impact on achieving value-based care objectives within ACOs. Speakers: This webinar was recored on June 20, 2024.
Leveraging Virtual Clinical Trials and Bio-simulations for Medication Safety and Pharmacovigilance
In this educational session, explore how virtual clinical trials and bio-simulations can make pharmacovigilance departments an integral part of the drug development process, reducing regulatory and financial risk for pharmaceutical companies.
